- Home
- INBS vs IBIO Comparison
INBS vs IBIO Comparison
Compare INBS & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- IBIO
- Stock Information
- Founded
- INBS 2016
- IBIO 2008
- Country
- INBS United States
- IBIO United States
- Employees
- INBS N/A
- IBIO N/A
- Industry
- INBS Medical Specialities
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- INBS Health Care
- IBIO Health Care
- Exchange
- INBS Nasdaq
- IBIO Nasdaq
- Market Cap
- INBS 8.7M
- IBIO 9.3M
- IPO Year
- INBS N/A
- IBIO N/A
- Fundamental
- Price
- INBS $1.24
- IBIO $0.73
- Analyst Decision
- INBS
- IBIO Strong Buy
- Analyst Count
- INBS 0
- IBIO 3
- Target Price
- INBS N/A
- IBIO $4.87
- AVG Volume (30 Days)
- INBS 113.6K
- IBIO 2.3M
- Earning Date
- INBS 05-13-2025
- IBIO 05-02-2025
- Dividend Yield
- INBS N/A
- IBIO N/A
- EPS Growth
- INBS N/A
- IBIO N/A
- EPS
- INBS N/A
- IBIO N/A
- Revenue
- INBS $2,936,472.00
- IBIO $375,000.00
- Revenue This Year
- INBS $280.88
- IBIO $36.00
- Revenue Next Year
- INBS $126.26
- IBIO N/A
- P/E Ratio
- INBS N/A
- IBIO N/A
- Revenue Growth
- INBS 3.87
- IBIO 650.00
- 52 Week Low
- INBS $1.00
- IBIO $0.64
- 52 Week High
- INBS $3.04
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- INBS 43.94
- IBIO 24.07
- Support Level
- INBS $1.16
- IBIO $0.75
- Resistance Level
- INBS $1.43
- IBIO $0.82
- Average True Range (ATR)
- INBS 0.10
- IBIO 0.14
- MACD
- INBS 0.02
- IBIO 0.10
- Stochastic Oscillator
- INBS 42.42
- IBIO 3.04
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.